Skip to main content
. 2018 Feb 1;28(1):47–54. doi: 10.1089/cap.2017.0047

Table 2.

Summary of Treatment-Emergent Adverse Events

  Total (N = 41)
Any TEAE 35 (85)
Serious TEAE 3 (7)
TEAE leading to withdrawal 4 (10)
TEAEs with overall incidence ≥5%
 Headache 11 (27)
 Nausea 8 (20)
 Dysmenorrheaa 4 (19)
 Vomiting 6 (15)
 Toothache 3 (7)
 Upper respiratory tract infection 3 (7)
 Weight increase 3 (7)

Values are number of patients (percentage).

a

Sex-specific event; data represent percentage of female patients.

TEAE, treatment-emergent adverse event.